Compare Stocks → At first glance, this chart looks like nonsense… (From The TradingPub) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:BFRINASDAQ:COCPNASDAQ:LFLYNASDAQ:MTBC Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBFRIBiofrontera$1.66+10.7%$1.37$0.61▼$13.42$8.45M0.83646,464 shs62,560 shsCOCPCocrystal Pharma$1.50-3.8%$1.49$1.33▼$3.29$15.26M1.3413,335 shs3,850 shsLFLYLeafly$2.12-0.5%$2.89$1.96▼$16.00$4.90M1.0677,189 shs7,740 shsMTBCCareCloud$3.10$2.50▼$6.75$47.64M0.8563,000 shs66,900 shs20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBFRIBiofrontera+10.67%-2.92%+40.68%+12.16%-85.97%COCPCocrystal Pharma-3.97%+4.90%0.00%-3.23%-40.48%LFLYLeafly-0.47%+1.92%-29.10%-54.89%-66.64%MTBCCareCloud0.00%0.00%0.00%0.00%0.00%$25,000 into $109,616 in two months? (Ad)Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBFRIBiofrontera2.4458 of 5 stars3.55.00.00.01.10.01.3COCPCocrystal Pharma2.1552 of 5 stars3.53.00.00.00.71.71.3LFLYLeafly2.5398 of 5 stars3.35.00.00.03.80.80.0MTBCCareCloudN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBFRIBiofrontera3.00Buy$18.00984.34% UpsideCOCPCocrystal Pharma3.00Buy$10.00566.67% UpsideLFLYLeafly2.50Moderate Buy$6.00183.02% UpsideMTBCCareCloudN/AN/AN/AN/ACurrent Analyst RatingsLatest LFLY, MTBC, COCP, and BFRI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/4/2024COCPCocrystal PharmaHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.004/1/2024LFLYLeaflyBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$11.00 ➝ $6.003/20/2024COCPCocrystal PharmaHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.00(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBFRIBiofrontera$34.07M0.25N/AN/A$3.16 per share0.53COCPCocrystal PharmaN/AN/AN/AN/A$2.59 per shareN/ALFLYLeafly$42.25M0.12N/AN/A($5.72) per share-0.37MTBCCareCloud$139.60M0.00N/A2.43$6.58 per share0.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBFRIBiofrontera-$20.13M-$15.82N/AN/AN/A-59.09%-344.98%-72.85%5/10/2024 (Estimated)COCPCocrystal Pharma-$17.98M-$1.99N/AN/AN/AN/A-59.62%-54.62%5/20/2024 (Estimated)LFLYLeafly-$9.50M-$4.92N/A∞N/A-22.48%N/A-39.85%5/9/2024 (Estimated)MTBCCareCloud$2.84M-$0.45N/AN/AN/A3.20%4.54%3.33%N/ALatest LFLY, MTBC, COCP, and BFRI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/28/2024Q4 2023COCPCocrystal Pharma-$0.57-$0.44+$0.13-$0.44N/AN/A3/28/2024Q4 2023LFLYLeafly-$1.41-$0.22+$1.19-$0.22$9.49 million$9.75 million3/15/2024Q4 2023BFRIBiofronteraN/A-$2.33-$2.33-$6.31N/A$10.60 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBFRIBiofronteraN/AN/AN/AN/AN/ACOCPCocrystal PharmaN/AN/AN/AN/AN/ALFLYLeaflyN/AN/AN/AN/AN/AMTBCCareCloudN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBFRIBiofronteraN/A1.280.67COCPCocrystal PharmaN/A8.928.92LFLYLeaflyN/A3.743.74MTBCCareCloudN/A1.211.19OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBFRIBiofrontera10.08%COCPCocrystal Pharma6.72%LFLYLeafly15.55%MTBCCareCloud19.68%Insider OwnershipCompanyInsider OwnershipBFRIBiofrontera0.21%COCPCocrystal Pharma25.06%LFLYLeafly11.30%MTBCCareCloud34.90%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableBFRIBiofrontera835.09 million5.08 millionNo DataCOCPCocrystal Pharma1210.17 million7.62 millionNot OptionableLFLYLeafly1302.30 million2.04 millionOptionableMTBCCareCloud4,10015.22 million9.91 millionNot OptionableLFLY, MTBC, COCP, and BFRI HeadlinesSourceHeadlineCCLD Stock Earnings: CareCloud Beats EPS, Misses Revenue for Q4 2023investorplace.com - March 21 at 12:09 PMCareCloud (CCLD) Earnings Dates & Reportsinvesting.com - March 3 at 3:18 PMCareCloud, Inc. (NASDAQ:CCLD) Q2 2023 Earnings Call Transcriptfinance.yahoo.com - August 10 at 4:54 PMCareCloud Inc Preferred Series B (CCLDO)investing.com - May 17 at 2:50 PMRevenue Cycle Management Market Technologies, Size and Market ... - Cottonwood Holladay Journalnews.google.com - May 11 at 6:23 PMCareCloud CEO Hadi Chaudhry Named Finalist for Ernst & Young's ... - GlobeNewswirenews.google.com - May 11 at 6:23 PMHealthcare Cloud Computing Market Share In 2023 | Important ... - Digital Journalnews.google.com - May 11 at 8:22 AMPodiatry EMR Software Market Size Analysis Report 2023-2030 by ... - Digital Journalnews.google.com - May 11 at 8:22 AMCareCloud Wins Best Overall EHR Solution Provider in 2023 MedTech Breakthrough Awards - CareCloud (NASDAQ - Benzinganews.google.com - May 10 at 5:20 PMMorning Medical Update: New breast cancer screening guidelines ... - Medical Economicsnews.google.com - May 10 at 12:19 PM3 lessons the HealthTech industry can learn from CareCloud - Medical Economicsnews.google.com - May 10 at 12:19 PMCareCloud's Bill Korn, Chief Strategy Officer, and Joseph DosSantos ... - GlobeNewswirenews.google.com - May 9 at 11:01 AMCareCloud Strengthens Leadership Team with Key Transitions - GlobeNewswirenews.google.com - May 8 at 8:00 PMCareCloud CFO Bill Korn Named to New Role as Chief Strategy Officer - MarketWatchnews.google.com - May 8 at 3:00 PMWorkable Strategic Report on Medical Practice Management (PMS ... - Digital Journalnews.google.com - May 8 at 9:59 AMCareCloud appoints DosSantos as CFO, Korn as CSO - Seeking Alphanews.google.com - May 8 at 9:59 AMCareCloud Strengthens Leadership Team with Key Transitions - Yahoo Financenews.google.com - May 8 at 9:59 AMRecent Digital Health Strategic Partnerships Round Up - HIT Consultantnews.google.com - May 5 at 5:46 PMEF Hutton Reiterates CareCloud (CCLD) Buy Recommendation - Nasdaqnews.google.com - May 5 at 5:46 PMRising Trends of Emergency Medicine EMR Software Market will ... - Digital Journalnews.google.com - May 5 at 12:46 PMCareCloud Reports First Quarter 2023 Results - Yahoo Financenews.google.com - May 5 at 12:46 PMCareCloud Declares Dividends on Non-Convertible Series A and ... - InvestorsObservernews.google.com - May 5 at 12:46 PMGastroenterology EMR and Billing Software Market Size 2023 | New ... - Digital Journalnews.google.com - May 5 at 7:37 AMNexa Healthcare Announces Partnership with NexHealth to Offer 24 ... - EIN Newsnews.google.com - May 4 at 4:36 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsBiofronteraNASDAQ:BFRIBiofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.Cocrystal PharmaNASDAQ:COCPCocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that has completed Phase I clinical trial for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. The company is headquartered in Bothell, Washington.LeaflyNASDAQ:LFLYLeafly Holdings, Inc. owns and operates a platform to provide consumers with cannabis information and connects consumers to cannabis brands and licensed retailers. The company offers subscription-based marketplace listings, digital advertising solutions, and software as a service-based tools to cannabis retailers; and information, reviews, menus, and ordering and delivery options to its audience through its website and mobile applications. Leafly Holdings, Inc. was founded in 2010 and is headquartered in Seattle, Washington.CareCloudNASDAQ:MTBCCareCloud, Inc. brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows, and make better business and care decisions. More than 40,000 providers across the United States count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Services and solutions include revenue cycle management (RCM), practice management (PM), electronic health record (EHR), business intelligence, telehealth, and patient experience management (PXM). CareCloud is headquartered in Somerset, NJ. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.